The Effect of Primary Cesarean Section Prevention on Maternal and Neonatal Outcomes
The study aimed to examine the effect of prolonging the second stage of labor on the rate of Cesarean section (CS), maternal and neonatal outcomes.
The study compared 2 time periods. The first time period was between May 2011 until April 2014 when a prolonged second stage in nulliparous women was considered three hours with regional anesthesia or two hours if no such anesthesia was provided. Second stage arrest was defined in multiparous women after two hours with regional anesthesia or one hour without it. The second time period was between May 2014 until April 2017, allowed nulliparous and multiparous women to continue the second stage of labor an additional one hour before diagnosing second-stage arrest. Singleton deliveries at or beyond 37 weeks' gestation were initially considered for eligibility.
調査の概要
詳細な説明
The study aimed to examine the effect of prolonging the second stage of labor on the rate of Cesarean section (CS), maternal and neonatal outcomes.
The study compared 2 time periods. The first time period was between May 2011 until April 2014 when a prolonged second stage in nulliparous women was considered three hours with regional anesthesia or two hours if no such anesthesia was provided. Second stage arrest was defined in multiparous women after two hours with regional anesthesia or one hour without it. The second time period was between May 2014 until April 2017, allowed nulliparous and multiparous women to continue the second stage of labor an additional one hour before diagnosing second-stage arrest. Singleton deliveries at or beyond 37 weeks' gestation were initially considered for eligibility.
The rate of CS, operative vaginal deliveries, 3rd and 4th degree lacerations, postpartum hemorrhage, arterial cord PH below 7 and admissions to the neonatal intensive care unit (NICU).
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Haifa、イスラエル
- Rambam Health Care Campus
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
1. Singleton deliveries at or beyond 37 weeks' gestation.
Exclusion Criteria:
- Non-vertex presentation.
- Trial of labor after CS.
- High risk pregnancy (multiple gestation, preeclampsia, diabetes mellitus, intrauterine growth restriction).
- Known fetal anomalies and intrauterine fetal demise.
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
---|---|
Prolonged second stage of labor
Women with prolonged second stage of labor as specified before.
|
To examine the effect of prolonging the second stage of labor on the rate of cesarean delivery, maternal and neonatal outcomes
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
The rate of primary CS.
時間枠:Between 2011 and 2017.
|
The rate of primary CS in percentage of the total participants.
|
Between 2011 and 2017.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
The rate of operative vaginal delivery.
時間枠:Between 2011 and 2017.
|
The rate of operative vaginal delivery in percentage of the total participants.
|
Between 2011 and 2017.
|
Post-partum hemorrhage.
時間枠:Between 2011 and 2017.
|
Post-partum hemorrhage as estimated in liters.
|
Between 2011 and 2017.
|
The need for blood transfusion.
時間枠:Between 2011 and 2017.
|
Number and type of blood products required post-partum and calculation of the number of patients that required blood products out of the total number of participants in percentage.
|
Between 2011 and 2017.
|
Third-and fourth-degree laceration rate.
時間枠:Between 2011 and 2017.
|
Third-and fourth-degree laceration rate of the total number of participants.
|
Between 2011 and 2017.
|
Chorioamnionitis rate.
時間枠:Between 2011 and 2017.
|
Chorioamnionitis rate in percentage of the total participants.
|
Between 2011 and 2017.
|
Admission to the NICU.
時間枠:Between 2011 and 2017.
|
Admission to the NICU in percentage of the total participants.
|
Between 2011 and 2017.
|
協力者と研究者
捜査官
- 主任研究者:Kamel Mattar, MD、Principal Investigator
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 0258-17-RMB
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Protocol changeの臨床試験
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); PENTA...完了
-
Northwestern UniversityNational Institute of Mental Health (NIMH)積極的、募集していない
-
University of Witwatersrand, South AfricaDepartment for International Development, United Kingdom; Medical Research Council, South Africa と他の協力者わからない
-
Hospital for Special Surgery, New York募集
-
University of Toronto Practice Based Research Network完了
-
Charles Drew University of Medicine and Science引きこもったCOVID19 | 2型糖尿病
-
Insel Gruppe AG, University Hospital Bern募集
-
University of MinnesotaNational Institute of Mental Health (NIMH); Michigan Department of Community Health完了
-
University of California, IrvineJacobs Foundation完了